Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Madersbacher

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
BJU International|May 8, 1999
Is transurethral resection of the prostate still justified?S Madersbacher, M Marberger
Der Urologe. Ausg. A|September 9, 2011
[Primary and secondary prevention of benign prostatic hyperplasia: current knowledge and implications for clinical management]M Oelke, S Madersbacher
Journal of Immunological Methods|April 8, 1991
Double wavelength measurement of 3,3',5,5'-tetramethylbenzidine (TMB) provides a three-fold enhancement of the ELISA measuring rangeS Madersbacher, P Berger
Journal D'Urologie|January 1, 1993
[Tissue ablation by high-intensity focused ultrasound in benign prostatic hypertrophy]S Madersbacher, M Marberger
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Minimal invasive therapy of benign prostatic hyperplasia]S Madersbacher, M Marberger
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Current drug therapy of benign prostatic hyperplasia]C P Schmidbauer, S Madersbacher
Der Urologe. Ausg. A|March 3, 2004
[Increasing importance of postoperative functional status]S Madersbacher, U E Studer
Current Opinion in Urology|October 13, 2006
Minimally invasive treatment for benign prostatic hyperplasiaS Madersbacher, B Djavan, M Marberger
European Urology|February 27, 2001
Management of lower urinary tract symptoms of elderly men in AustriaS Madersbacher, G Haidinger, G Struhal, et al.
Ultrasonics Sonochemistry|April 1, 1997
Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical applicationS Madersbacher, C Kratzik, M Marberger
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
BJU International|May 8, 1999
Is transurethral resection of the prostate still justified?S Madersbacher, M Marberger
Der Urologe. Ausg. A|September 9, 2011
[Primary and secondary prevention of benign prostatic hyperplasia: current knowledge and implications for clinical management]M Oelke, S Madersbacher
Journal of Immunological Methods|April 8, 1991
Double wavelength measurement of 3,3',5,5'-tetramethylbenzidine (TMB) provides a three-fold enhancement of the ELISA measuring rangeS Madersbacher, P Berger
Journal D'Urologie|January 1, 1993
[Tissue ablation by high-intensity focused ultrasound in benign prostatic hypertrophy]S Madersbacher, M Marberger
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Minimal invasive therapy of benign prostatic hyperplasia]S Madersbacher, M Marberger
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Current drug therapy of benign prostatic hyperplasia]C P Schmidbauer, S Madersbacher
Der Urologe. Ausg. A|March 3, 2004
[Increasing importance of postoperative functional status]S Madersbacher, U E Studer
Current Opinion in Urology|October 13, 2006
Minimally invasive treatment for benign prostatic hyperplasiaS Madersbacher, B Djavan, M Marberger
European Urology|February 27, 2001
Management of lower urinary tract symptoms of elderly men in AustriaS Madersbacher, G Haidinger, G Struhal, et al.
Ultrasonics Sonochemistry|April 1, 1997
Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical applicationS Madersbacher, C Kratzik, M Marberger
Pageof 14